Nanoprobes for deep-tissue optical imaging of proteins in neurons
April 1, 2014
In a potential breakthrough in brain-tissue imaging, Lawrence Berkeley National Laboratory (Berkeley Lab) researchers have developed ultra-tiny (sub-10-nanometers), ultra-bright nanoprobes for single-molecule deep-tissue optical imaging of proteins in neurons in the brain and other tissues.
Scientists often study proteins within cells by labeling them with light-emitting probes, but finding probes that are bright enough for imaging — but not so large as to disrupt the protein’s function — has been a challenge.
Fluorescent organic dye molecules and semiconductor quantum dots meet the size requirements but impose other limitations.
“Organic dyes and quantum dots will blink, meaning they randomly turn on and off, which is quite problematic for single-molecule imaging, and will photobleach and turn-off permanently, usually after less than 10 seconds under most imaging conditions,” says James Schuck, who directs the Berkeley Lab’s Molecular Foundry’s Imaging and Manipulation of Nanostructures Facility.
So five years ago, researchers at the Molecular Foundry synthesized and imaged single nanoparticles from nanocrystals of sodium yttrium fluoride (NaYF4) doped with trace amounts of the lanthanide elements ytterbium and erbium.
These nanoparticles are able to upconvert near-infrared photons into green or red visible light (for use in microscopes), and their photostability makes them potentially ideal luminescent probes for single-molecule imaging. (Upconversion is the process by which a molecule absorbs two or more photons at a lower energy and emits them at higher energies.)
The researchers have now found that they can also reduce the size of these nanoparticles to as small as 4.8 nanometers without loss of brightness by raising erbium concentration and reducing ytterbium concentration.
This research was published in Nature Nanotechnology and supported by the DOE Office of Science.
Abstract of Nature Nanotechnology paper